BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21717820)

  • 1. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness research: a progress report.
    Sox HC
    Ann Intern Med; 2010 Oct; 153(7):469-72. PubMed ID: 20679544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
    Selby J; Slutsky J
    J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.
    Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD
    J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of comparative effectiveness on U.S. healthcare providers.
    Bigalke JT
    Healthc Financ Manage; 2009 Oct; 63(10):74-8. PubMed ID: 19810656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the long-term impact of public investments in comparative effectiveness research: conceptual framework and lessons learned.
    Rich EC; Esposito D; Kimmey LD; Valenzano CS; Yong PL
    J Comp Eff Res; 2014 Nov; 3(6):657-66. PubMed ID: 25494572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 12. Science and the stimulus. Science and the stimulus.
    Mervis J
    Science; 2009 Nov; 326(5957):1176-7. PubMed ID: 19965443
    [No Abstract]   [Full Text] [Related]  

  • 13. Research funding. Health bill backs evidence-based medicine, new drug studies.
    Kaiser J
    Science; 2010 Mar; 327(5973):1562. PubMed ID: 20339036
    [No Abstract]   [Full Text] [Related]  

  • 14. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building sustainable multi-functional prospective electronic clinical data systems.
    Randhawa GS; Slutsky JR
    Med Care; 2012 Jul; 50 Suppl():S3-6. PubMed ID: 22692255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited article: comparative effectiveness research, evidence-based medicine, and the AAN.
    French JA; England JD
    Neurology; 2010 Aug; 75(6):562-7. PubMed ID: 20697109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The past, present, and future of comparative effectiveness research in the US Department of Veterans Affairs.
    Kupersmith J; Ommaya AK
    Am J Med; 2010 Dec; 123(12 Suppl 1):e3-7. PubMed ID: 21184864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.